Brii Biosciences Ltd
HKEX:2137
Brii Biosciences Ltd
HKEX:2137
Price:
1.41
HKD
-0.7%
Market Closed
Market Cap:
HK$1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Brii Biosciences Ltd
HKEX:2137
|
CN |
|
Clinigen Group PLC
LSE:CLIN
|
UK |
|
China Zenith Chemical Group Ltd
HKEX:362
|
HK |
|
Nifco Inc
TSE:7988
|
JP |
|
T
|
Terna Energy SA
ATHEX:TENERGY
|
GR |
|
Takeda Printing Co Ltd
TSE:7875
|
JP |
Balance Sheet
Balance Sheet Decomposition
Brii Biosciences Ltd
Brii Biosciences Ltd
Balance Sheet Decomposition is not available for
Brii Biosciences Ltd
Brii Biosciences Ltd
Balance Sheet
Brii Biosciences Ltd
Brii Biosciences Ltd
Currency: CNY
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
880
|
1 035
|
2 855
|
1 191
|
979
|
1 003
|
607
|
|
| Cash |
0
|
0
|
0
|
0
|
490
|
0
|
0
|
|
| Cash Equivalents |
880
|
1 035
|
2 855
|
1 191
|
490
|
1 003
|
607
|
|
| Short-Term Investments |
0
|
20
|
500
|
1 807
|
2 171
|
1 317
|
1 333
|
|
| Total Receivables |
0
|
0
|
52
|
58
|
71
|
0
|
0
|
|
| Other Current Assets |
5
|
38
|
8
|
22
|
51
|
94
|
23
|
|
| Total Current Assets |
885
|
1 093
|
3 414
|
3 077
|
2 783
|
2 414
|
1 963
|
|
| PP&E Net |
57
|
44
|
33
|
20
|
6
|
14
|
14
|
|
| PP&E Gross |
57
|
44
|
33
|
20
|
6
|
14
|
0
|
|
| Accumulated Depreciation |
3
|
8
|
13
|
18
|
23
|
25
|
0
|
|
| Intangible Assets |
0
|
12
|
10
|
147
|
267
|
180
|
298
|
|
| Long-Term Investments |
95
|
117
|
152
|
146
|
142
|
9
|
7
|
|
| Other Long-Term Assets |
2
|
2
|
3
|
3
|
0
|
89
|
77
|
|
| Total Assets |
1 039
N/A
|
1 268
+22%
|
3 612
+185%
|
3 392
-6%
|
3 198
-6%
|
2 707
-15%
|
2 360
-13%
|
|
| Liabilities | ||||||||
| Accrued Liabilities |
13
|
350
|
173
|
48
|
48
|
39
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
8
|
8
|
9
|
10
|
3
|
5
|
5
|
|
| Other Current Liabilities |
40
|
217
|
99
|
171
|
75
|
34
|
27
|
|
| Total Current Liabilities |
62
|
575
|
281
|
229
|
126
|
77
|
32
|
|
| Long-Term Debt |
1 562
|
2 423
|
13
|
3
|
0
|
23
|
4
|
|
| Minority Interest |
0
|
4
|
32
|
37
|
47
|
51
|
52
|
|
| Other Liabilities |
28
|
12
|
7
|
2
|
0
|
0
|
0
|
|
| Total Liabilities |
1 652
N/A
|
3 006
+82%
|
269
-91%
|
197
-27%
|
79
-60%
|
50
-37%
|
16
N/A
|
|
| Equity | ||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
661
|
1 909
|
6 013
|
6 447
|
6 572
|
7 078
|
2 376
|
|
| Additional Paid In Capital |
62
|
74
|
9 317
|
9 352
|
9 377
|
9 390
|
0
|
|
| Unrealized Security Profit/Loss |
3
|
19
|
12
|
18
|
37
|
45
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
11
|
78
|
26
|
308
|
352
|
390
|
0
|
|
| Total Equity |
613
N/A
|
1 738
-184%
|
3 343
N/A
|
3 195
-4%
|
3 119
-2%
|
2 657
-15%
|
2 376
-11%
|
|
| Total Liabilities & Equity |
1 039
N/A
|
1 268
+22%
|
3 612
+185%
|
3 392
-6%
|
3 198
-6%
|
2 707
-15%
|
2 360
-13%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
706
|
706
|
720
|
727
|
729
|
731
|
721
|
|
Switch to:
Switch to:
See Also
Discover More
